Table 2. Abi1 expression in analyzed samples.
Abi1 score | ± SD | n | ||
Healthy Mucosa (HM) | 2.46 | 1.15 | 24 | |
Right Colon (R) | 3.19 | 1.52 | 13 | |
Left colon (L) | 2.59 | 1.12 | 11 | |
Inflamed Mucosa (IM) | 4 | 1.05 | 9 | |
HPP | ||||
HPP wt | 2.66 | 0.5 | 9 | |
HPP BRAFc600 | 3 | 1.26 | 6 | |
HPP KRAS c12/13 | 5.38 | 0.52 | 8 | |
SSA/P | SSA/P wt | 4.66 | 0.58 | 3 |
SSA/P BRAF c600 | 4.64 | 1.01 | 14 | |
SSA/P KRAS c12/13 | 5 | 1 | 3 | |
TSA | TSA wt | 5 | 1.15 | 4 |
TSA KRAS c12/13 | 5.25 | 0.96 | 4 | |
TbA | TbA wt | 4.86 | 0.99 | 8 |
TbA BRAF c600 | 5 | n.a. | 1 | |
TbA KRAS c12/13 | 5.75 | 0.96 | 4 | |
Ca | Ca wt | 4.56 | 1.33 | 9 |
Ca BRAF c600 | 3 | n.a. | 1 | |
Ca KRAS c12/13 | 5.8 | 0.79 | 10 | |
Ca MSI | 5.33 | 1.15 | 3 | |
Met | Met wt | 5.14 | 1.07 | 7 |
Met KRAS c12/13 | 4.5 | 0.7 | 2 |
All values shown as mean ± SD; abbreviations: HPP: hyperplastic polyp; SSA/P: sessile serrated polyp/adenoma; TSA: traditional serrated adenoma; TbA: tubular adenoma; Ca: invasive colorectal carcinoma; Met: Metastasis; BRAF c600: B1 Rapidly accelerated fibrosarcoma codon 600 mutation; KRAS c12/13: Kirsten rat sarcoma codon 12/13 mutationMSI: microsatellite instable tumors; n: number of examined samples; n.a.: not applicable due to low sample number.